Groningen, Netherlands

Tomas Gerrit Kloosterman

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tomas Gerrit Kloosterman

Introduction

Tomas Gerrit Kloosterman is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of medical research, particularly in the development of vaccines. His work focuses on identifying essential proteins and genes that play a crucial role in the virulence of pneumococcal infections.

Latest Patents

Kloosterman holds a patent for his invention related to virulence factors. The patent provides proteins and genes that are essential for survival and virulence in vivo, making them ideal candidates for vaccine preparation against pneumococcal infection. Additionally, the invention includes antibodies against these proteins, further enhancing its potential for medical applications. He has 1 patent to his name.

Career Highlights

Kloosterman is affiliated with the Radboud University Nijmegen Medical Centre, where he conducts his research. His work has been instrumental in advancing our understanding of pneumococcal infections and developing effective vaccines. His dedication to medical research has positioned him as a valuable contributor to the scientific community.

Collaborations

Throughout his career, Kloosterman has collaborated with esteemed colleagues, including Hester Jeanette Bootsma and Pieter Jan Burghout. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

Tomas Gerrit Kloosterman's contributions to the field of medical research, particularly in vaccine development, highlight his importance as an inventor. His innovative work continues to pave the way for advancements in combating pneumococcal infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…